University of Maryland
Develop and validate genomic-derived biomarkers for the early detection of esophageal cancer.
Esophageal carcinoma is usually detected at an advanced stage, when available treatments are not very effective. Earlier detection of this cancer has been shown to have a significant impact on patient outcome.
- Identify gene expression panels and individual gene biomarkers to distinguish between patients with and without esophageal cancer, using cDNA microarrays and specimens from patients with Barrett’s esophagus without cancer and from patients with Barrett’s adenocarcinoma.
- Confirm these expression panels and individual genes with quantitative real time-PCR using a capillary microfluidics station-based method.
- Perform cross-sectional retrospective longitudinal validation studies using this quantitative real time-PCR method.
Meltzer, Stephen, M.D.
> University of Maryland<br> Dept. of Medicine
> Div. of Gastroenterology, N3W62<br> 22 S. Greene St.
> Baltimore, MD 21201 <p>
Phone (410) 328-5780
> Fax: (410) 328-8315<br> Email: firstname.lastname@example.org